Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2018

View Archived Issues

JZTX-V, compound isolated from Chilobrachys spider, found to restore learning and memory in AD

Shanghai Longwood Biopharmaceuticals divulges JAK inhibitors

Medshine Discovery and collaborator patent MAP3K5 inhibitors

Yafei Shanghai Biomedical Technology divulges drug conjugates for cancer

Shenzhen Targetrx Biotechnology discloses Bcr-Abl1 inhibitors

FDA approves Jornay PM extended-release capsules for the treatment of ADHD

AstraZeneca discovers JAK1 inhibitors

IMV reaches important milestones in advanced ovarian cancer clinical trial

Epilepsy-associated de novo variants in GABRs alter GABA(A) receptor function

Inhibitors of "undruggable" enzymes induce tumor arrest

Gemphire Therapeutics halts pediatric NAFLD study of gemcabene

New review on glyphosate evaluating mechanisms, regulatory framework and research prospects

I-Mab cleared to conduct clinical trial of TJ-103 in China

Petrovax Pharm's 4-valeant influenza vaccine --Grippol Quadrivalent-- approved in Russia

Global phase III trial of Celltrion's bevacizumab biosimilar begins

FDA approves Arakoda for prevention of malaria

Basilea Pharmaceutica starts second registrational phase III study of ceftobiprole

Phase III study of JCR Pharmaceuticals' JR-141 for Hunter syndrome begins

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...